More recently, encouraging clinical results from a triple-hormone-receptor agonist, Retatrutide, and several GLP-1R/GCGR dual agonists, suggest that GCGR could be a promising co-stimulating target for type 2 diabetes and obesity
- Nutricost EAA c sn xut ti c s tun th cc tiu chun GMP v FDA, m bo tin cy, an ton v cht lng ca sn phm vi chng nhn ISO
In studies on gastric ulcers, Moringa was shown to reduce stomach acidity by 86.15 and 85.13% at doses of 500 and 350 mg, respectively, indicating its potential use as an antiulcer drug (Choudhary et al
10.1016/j.ejphar.2019.172835 [DOI] [PubMed] [Google Scholar] Smith C., Patterson-Cross R., Woodward O., Lewis J., Chiarugi D., Merkle F., et al
Animal studies on intestinal healing, inflammatory bowel disease, and gut permeability have repeatedly demonstrated that oral BPC-157 performs comparably to injected BPC-157 for gastrointestinal endpoints